• Subscribe
  • Magazine
  • Videos
  • Advertise
  • About Us
  • Smart Water Summit
  • Wastewater Summit
    • Recent Quotes
    My Watchlist
    Indicators
    WaterWorld Market Index
    Markets
    Stocks
    ETFs
    Tools
    Overview
    News
    Currencies
    International
    Treasuries

    NovaBay Pharmaceuticals, Inc. Common Stock (NY: NBY )

    0.6770 +0.0270 (+4.15%)
    Official Closing Price Updated: 8:00 PM EST, Feb 10, 2025 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    Price and Volume

    Detailed Quote
    Volume 51,907
    Open 0.6600
    Bid (Size) 0.6503 (13)
    Ask (Size) 0.6900 (1)
    Prev. Close 0.6500
    Today's Range 0.6300 - 0.6770
    52wk Range 0.3611 - 9.079
    Shares Outstanding 30,098,150
    Dividend Yield N/A
    Chart for (: )
    Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

    Top News

    More News
    12 Health Care Stocks Moving In Wednesday's Pre-Market Session
    Via Benzinga
    NovaBay Pharmaceuticals Completes the Sale of its Eyecare Business to PRN and Further Adjourns its Special Meeting of Stockholders on Dissolution Proposal
    From NovaBay Pharmaceuticals, Inc.
    Via Business Wire

    Performance

    YTD
    +8.32%
    +8.32%
    1 Month
    -10.33%
    -10.33%
    3 Month
    -3.99%
    -3.99%
    6 Month
    +62.70%
    +62.70%
    1 Year
    -86.53%
    -86.53%

    More News

    Read More
    12 Health Care Stocks Moving In Monday's Pre-Market Session
    Via Benzinga
    NovaBay Pharmaceuticals Announces the Further Adjournment of the Special Meeting of Stockholders
    From NovaBay Pharmaceuticals
    Via Business Wire
    NovaBay CEO Letter to Stockholders Urges a FOR Vote at Upcoming Reconvened Special Meeting
    From NovaBay Pharmaceuticals, Inc.
    Via Business Wire
    NovaBay Pharmaceuticals to Reconvene Special Meeting of Stockholders on December 18, 2024
    From NovaBay Pharmaceuticals
    Via Business Wire
    NovaBay Pharmaceuticals Reports Third Quarter 2024 Financial Results
    From NovaBay Pharmaceuticals, Inc.
    Via Business Wire
    NovaBay Pharmaceuticals Accepts Revised Offer from PRN Physician Recommended Nutriceuticals, LLC and Enters into an Amendment to the Asset Purchase Agreement to Increase Purchase Price
    From NovaBay Pharmaceuticals, Inc.
    Via Business Wire
    Prominent Independent Proxy Advisory Firm ISS Supports NovaBay Pharmaceuticals’ Proposals to Authorize the Sale of its Avenova Brand
    From NovaBay Pharmaceuticals, Inc.
    Via Business Wire
    12 Health Care Stocks Moving In Tuesday's Pre-Market Session
    Via Benzinga
    NovaBay Pharmaceuticals Board Determines Unsolicited Offer is Superior to Asset Purchase Agreement with PRN Physician Recommended Nutriceuticals, LLC
    From NovaBay Pharmaceuticals, Inc.
    Via Business Wire
    What's Going On With NovaBay Pharmaceuticals Shares Friday?
    Via Benzinga
    NBY Stock Alert: Halper Sadeh LLC Is Investigating Whether the Sale of NovaBay Pharmaceuticals, Inc.’s Avenova Brand and Business Is Fair to Shareholders
    From Halper Sadeh LLC
    Via Business Wire
    NovaBay Pharmaceuticals Signs Definitive Agreement to Sell its Avenova Assets
    From NovaBay Pharmaceuticals, Inc.
    Via Business Wire
    NBY Stock Earnings: NovaBay Pharmaceuticals Misses EPS, Misses Revenue for Q2 2024
    Via InvestorPlace
    NovaBay Pharmaceuticals Reports Second Quarter 2024 Financial Results
    From NovaBay Pharmaceuticals, Inc.
    Via Business Wire
    NovaBay Pharmaceuticals to Hold Second Quarter 2024 Conference Call on August 13, 2024
    From NovaBay Pharmaceuticals, Inc.
    Via Business Wire
    NovaBay Pharmaceuticals Reports Record Amazon Prime Day Sales
    From NovaBay Pharmaceuticals, Inc.
    Via Business Wire
    What's Going On With NovaBay Pharmaceuticals (NBY) Stock?
    Via Benzinga
    NovaBay Pharmaceuticals Announces Closing of $3.87 Million Underwritten Public Offering, Including Partial Exercise of Overallotment Option
    From NovaBay Pharmaceuticals, Inc.
    Via Business Wire
    S&P 500 Gains Over 1%; 3M Shares Jump After Q2 Results
    Via Benzinga
    Topics Stocks
    Exposures US Equities
    Why NovaBay Pharmaceuticals (NBY) Stock Is Down 60%
    Via Benzinga
    Crude Oil Down Over 2%; Bristol Myers Squibb Posts Upbeat Q2 Results
    Via Benzinga
    Exposures Fossil Fuels
    Why Saia Shares Are Trading Lower? Here Are Other Stocks Moving In Friday's Mid-Day Session
    Via Benzinga
    Dow Surges 550 Points; Headline PCE Price Index Falls To 2.5%
    Via Benzinga
    Topics Stocks
    Exposures US Equities
    Stock Quote API & Stock News API supplied by www.cloudquote.io
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the following
    Privacy Policy and Terms and Conditions.